A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/25/2011	US8044038 Crystallization process of quetiapine hemifumarate
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/25/2011	CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/25/2011	CA2518299C 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives
10/25/2011	CA2516937C Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives and theiruse against neurogenerative diseases
10/25/2011	CA2486380C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/25/2011	CA2445612C Methods and compositions for treating mammalian nerve tissue injuries
10/25/2011	CA2437866C Novel clock gene bmal2
10/20/2011	WO2011130741A1 Compounds for treating neurodegenerative diseases
10/20/2011	WO2011130675A2 Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof
10/20/2011	WO2011130615A2 Preparation of lacosamide
10/20/2011	WO2011130383A1 Compounds containing fused rings which inhibit beta-secretase activity and methods of use thereof
10/20/2011	WO2011130347A2 Methods for enhancing axonal regeneration
10/20/2011	WO2011130194A2 Methods for producing viloxazine salts and novel polymorphs thereof
10/20/2011	WO2011128810A1 Statins for the prevention or treatment of drug addictions
10/20/2011	WO2011128455A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/20/2011	WO2011128413A1 Process for the production of polymorph form i of agomelatine
10/20/2011	WO2011128370A1 Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof
10/20/2011	WO2011128279A1 Arylethynyl derivatives
10/20/2011	WO2011128265A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e] azulenes as vasopressin antagonists
10/20/2011	WO2011127989A1 Nicotine conjugate vaccine
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011127580A1 Compositions and methods for brain delivery of analgesic peptides
10/20/2011	WO2011101304A3 Piperidine derivatives
10/20/2011	WO2011078479A3 A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof
10/20/2011	WO2011072257A3 Amyloid binding agents
10/20/2011	WO2011069063A3 Multicyclic compounds and methods of use thereof
10/20/2011	WO2011066374A3 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
10/20/2011	WO2011066371A3 Antibodies to il-6 and use thereof
10/20/2011	WO2011055965A3 Methods for treating attention-deficit/hyperactivity disorder
10/20/2011	WO2011047173A9 Pharmaceutical compositions for oral administration
10/20/2011	WO2011036297A3 Method for the therapy and diagnosis of alzheimer's disease
10/20/2011	WO2011025230A9 Gaba release-regulating agent in cerebellum
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257628 Instrument for alleviating addictive drug craving, method for using same and method for treating addictive drug dependence
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257267 Reducing the Risk of Pathological Effects of Traumatic Brain Injury
10/20/2011	US20110257260 3,4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor
10/20/2011	US20110257256 Cannabinoids for use in treating or preventing cognitive impairment and dementia
10/20/2011	US20110257255 Composition and method for inhibition of nerve transmission
10/20/2011	US20110257247 Method of Treating Neurodegenerative Disease
10/20/2011	US20110257244 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof
10/20/2011	US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011	US20110257242 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257241 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257230 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257229 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/20/2011	US20110257228 Liquid pharmaceutical compositions comprising a triptan compound and xylitol
10/20/2011	US20110257227 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
10/20/2011	US20110257225 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257220 3,11 b-cis-Dihydrotetrabenazine for the Treatment of Schizophrenia and Other Psychoses
10/20/2011	US20110257214 Morphinan compounds
10/20/2011	US20110257213 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257209 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257198 Piperidine derivatives useful as orexin antagonists
10/20/2011	US20110257193 Fused imidazole derivatives as trpv3 antagonist
10/20/2011	US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257163 Gamma secretase modulators
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257159 Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
10/20/2011	US20110257157 Thiolactams and uses thereof
10/20/2011	US20110257156 Gamma secretase modulators
10/20/2011	US20110257148 Novel 1-alkyl-3-hydroxy-3-phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257145 Method of treating neurological diseases
10/20/2011	US20110257134 CO-CRYSTALS OF TRAMADOL AND NSAIDs
10/20/2011	US20110257133 Dosage regimen for a s1p receptor agonist
10/20/2011	US20110257127 A2b adenosine receptor antagonists
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257113 Method for Inducing a Trif-Bias
10/20/2011	US20110257109 Use of drugs that activate p2y receptors to enhance synaptogenesis
10/20/2011	US20110257106 Polymer Stabilized Neuropeptides
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257101 Catecholamine regulated protein
10/20/2011	US20110257074 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation
10/20/2011	US20110256569 Complex of a chaperone with beta-amyloid and methods employing this complex
10/20/2011	US20110256245 Methods and compositions of cannabis extracts
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256226 Opioid agonist formulations with releasable and sequestered antagonist
10/20/2011	US20110256223 Gastric retained gabapentin dosage form
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256150 Modulation of Axon Degeneration

1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 1833